Literature DB >> 9626045

An antibody raised against a conserved sequence of the prion protein recognizes pathological isoforms in human and animal prion diseases, including Creutzfeldt-Jakob disease and bovine spongiform encephalopathy.

P Piccardo1, J P Langeveld, A F Hill, S R Dlouhy, K Young, G Giaccone, G Rossi, M Bugiani, O Bugiani, R H Meloen, J Collinge, F Tagliavini, B Ghetti.   

Abstract

Antibodies to the prion protein (PrP) have been critical to the neuropathological and biochemical characterization of PrP-related degenerative diseases in humans and animals. Although PrP is highly conserved evolutionarily, there is some sequence divergence among species; as a consequence, anti-PrP antibodies have a wide spectrum of reactivity (from strong immunopositivity to lack of reactivity) when challenged with PrP from diverse species. We have produced an antibody (anti-PrP95-108) raised against a synthetic peptide corresponding to residues 95 to 108 of human PrP and have characterized it by epitope mapping, Western immunoblot analysis, and immunohistochemistry. The antibody recognizes not only human PrP isoforms but also pathological PrP from all species tested (ie, cattle, sheep, hamsters, and mice). This is probably due to the fact that the epitope recognized by this antibody includes residues 100 to 108 of human PrP, a sequence that is also present in PrP of several other species. Thus, this reagent is valuable not only for the study of human prion diseases but also for analysis of the possible relationship between human and animal disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626045      PMCID: PMC1858454     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids.

Authors:  T Kitamoto; K Ogomori; J Tateishi; S B Prusiner
Journal:  Lab Invest       Date:  1987-08       Impact factor: 5.662

3.  A novel method for producing anti-peptide antibodies. Production of site-specific antibodies to the T cell antigen receptor beta-chain.

Authors:  D N Posnett; H McGrath; J P Tam
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

4.  Isolation of a cDNA clone encoding the leader peptide of prion protein and expression of the homologous gene in various tissues.

Authors:  N K Robakis; P R Sawh; G C Wolfe; R Rubenstein; R I Carp; M A Innis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.

Authors:  H M Geysen; R H Meloen; S J Barteling
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  Different forms of the bovine PrP gene have five or six copies of a short, G-C-rich element within the protein-coding exon.

Authors:  W Goldmann; N Hunter; T Martin; M Dawson; J Hope
Journal:  J Gen Virol       Date:  1991-01       Impact factor: 3.891

7.  Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues.

Authors:  R W Shin; T Iwaki; T Kitamoto; J Tateishi
Journal:  Lab Invest       Date:  1991-05       Impact factor: 5.662

8.  Prion (PrPSc)-specific epitope defined by a monoclonal antibody.

Authors:  C Korth; B Stierli; P Streit; M Moser; O Schaller; R Fischer; W Schulz-Schaeffer; H Kretzschmar; A Raeber; U Braun; F Ehrensperger; S Hornemann; R Glockshuber; R Riek; M Billeter; K Wüthrich; B Oesch
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

9.  Distinct prion proteins in short and long scrapie incubation period mice.

Authors:  D Westaway; P A Goodman; C A Mirenda; M P McKinley; G A Carlson; S B Prusiner
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

10.  Two alleles of a neural protein gene linked to scrapie in sheep.

Authors:  W Goldmann; N Hunter; J D Foster; J M Salbaum; K Beyreuther; J Hope
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

View more
  10 in total

1.  Conformational conversion and prion disease.

Authors:  Liang Shen; Hong-Fang Ji
Journal:  Nat Rev Mol Cell Biol       Date:  2011-04       Impact factor: 94.444

2.  Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations.

Authors:  P Piccardo; J J Liepnieks; A William; S R Dlouhy; M R Farlow; K Young; D Nochlin; T D Bird; R R Nixon; M J Ball; C DeCarli; O Bugiani; F Tagliavini; M D Benson; B Ghetti
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

3.  Tetracyclines affect prion infectivity.

Authors:  Gianluigi Forloni; Selina Iussich; Tazeen Awan; Laura Colombo; Nadia Angeretti; Laura Girola; Ilaria Bertani; Giorgio Poli; Maria Caramelli; Maria Grazia Bruzzone; Laura Farina; Lucia Limido; Giacomina Rossi; Giorgio Giaccone; James W Ironside; Orso Bugiani; Mario Salmona; Fabrizio Tagliavini
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

4.  Evaluation of quinacrine treatment for prion diseases.

Authors:  A Barret; F Tagliavini; G Forloni; C Bate; M Salmona; L Colombo; A De Luigi; L Limido; S Suardi; G Rossi; F Auvré; K T Adjou; N Salès; A Williams; C Lasmézas; J P Deslys
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

5.  PrP(C) association with lipid rafts in the early secretory pathway stabilizes its cellular conformation.

Authors:  Daniela Sarnataro; Vincenza Campana; Simona Paladino; Mariano Stornaiuolo; Lucio Nitsch; Chiara Zurzolo
Journal:  Mol Biol Cell       Date:  2004-06-30       Impact factor: 4.138

6.  Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice.

Authors:  Jonathan D F Wadsworth; Susan Joiner; Jacqueline M Linehan; Melanie Desbruslais; Katie Fox; Sharon Cooper; Sabrina Cronier; Emmanuel A Asante; Simon Mead; Sebastian Brandner; Andrew F Hill; John Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-03       Impact factor: 11.205

7.  Conversion of the BASE prion strain into the BSE strain: the origin of BSE?

Authors:  Raffaella Capobianco; Cristina Casalone; Silvia Suardi; Michela Mangieri; Claudia Miccolo; Lucia Limido; Marcella Catania; Giacomina Rossi; Giuseppe Di Fede; Giorgio Giaccone; Maria Grazia Bruzzone; Ludovico Minati; Cristiano Corona; Pierluigi Acutis; Daniela Gelmetti; Guerino Lombardi; Martin H Groschup; Anne Buschmann; Gianluigi Zanusso; Salvatore Monaco; Maria Caramelli; Fabrizio Tagliavini
Journal:  PLoS Pathog       Date:  2007-03       Impact factor: 6.823

8.  Mapping of possible prion protein self-interaction domains using peptide arrays.

Authors:  Alan Rigter; Jan P M Langeveld; Drophatie Timmers-Parohi; Jorg G Jacobs; Peter L J M Moonen; Alex Bossers
Journal:  BMC Biochem       Date:  2007-04-12       Impact factor: 4.059

9.  Transmission of cervid prions to humanized mice demonstrates the zoonotic potential of CWD.

Authors:  Samia Hannaoui; Irina Zemlyankina; Sheng Chun Chang; Maria Immaculata Arifin; Vincent Béringue; Debbie McKenzie; Hermann M Schatzl; Sabine Gilch
Journal:  Acta Neuropathol       Date:  2022-08-22       Impact factor: 15.887

10.  Structure of Tau filaments in Prion protein amyloidoses.

Authors:  Grace I Hallinan; Md Rejaul Hoq; Manali Ghosh; Frank S Vago; Anllely Fernandez; Holly J Garringer; Ruben Vidal; Wen Jiang; Bernardino Ghetti
Journal:  Acta Neuropathol       Date:  2021-06-14       Impact factor: 17.088

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.